Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet's syndrome patients: a preliminary case-control study.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
08 2019
Historique:
received: 30 08 2018
accepted: 15 02 2019
pubmed: 2 3 2019
medline: 25 2 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

The Endoplasmic reticulum aminopeptidase protein 1 (ERAP1) trims N-terminal amino acids from epitope precursors for Major Histocompatibility Complex class I presentation. Genome-wide association studies demonstrated that ERAP1 gene single nucleotide polymorphisms (SNPs) are associated with Behçet's syndrome (BS). This study was conducted on the two most consistently BS-associated ERAP1 polymorphisms, rs17482078 (NG_027839.1:g.35983G>A) and rs27044 (NG_027839.1:g.35997C>G) to analyse their distribution in 55 Italian BS patients and 65 ethnically matched controls (healthy controls, HC) and to test their association with BS risk. SNPs were detected by isolation, amplification of genomic DNA and direct sequencing. SNPs functional effects were predicted by bioinformatics software. The odds ratio (OR) with 95% confidence intervals was calculated to assess the strength of BS association for genotypes and alleles, also validated by logistic regression (LR). LR was used to test the association between both SNPs and patients HLA genetic data. Bonferroni correction was also applied. Comparing patients and controls, we found a significant higher frequency of rs17482078 A allele (32.73% BS vs 17.69% HC, p = 0.007) and AA genotype (18.18% BS vs 0% HC; p = 0.0003) and rs27044 G allele (63.64% BS vs 46.92% HC; p = 0.0096) in BS group after Bonferroni correction. No association was found between HLA-B*51 and both ERAP1 SNPs. Although preliminary, our data show a stronger association of rs17482078 with BS compared to rs27044 by means of case-control genetic analysis and bioinformatics prediction of protein structure change. A larger series of patients and controls is required to confirm our preliminary findings.

Identifiants

pubmed: 30820838
doi: 10.1007/s11739-019-02056-w
pii: 10.1007/s11739-019-02056-w
doi:

Substances chimiques

Minor Histocompatibility Antigens 0
Aminopeptidases EC 3.4.11.-
ERAP1 protein, human EC 3.4.11.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

713-718

Commentaires et corrections

Type : CommentIn

Références

Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2016) One year in review 2016: Behçet’s syndrome. Clin Exp Rheumaol 34(Suppl 102):10–22
Leccese P, Yazici Y, Olivieri I (2017) Behcet’s syndrome in non endemic regions. Curr Opin Rheumatol 29(1):12–16
doi: 10.1097/BOR.0000000000000349 pubmed: 27684358
Takeuchi M, Kastner DL, Remmers EF (2015) The immunogenetics of Behçet’s disease: a comprehensive review. J Autoimmun 64:137–148
doi: 10.1016/j.jaut.2015.08.013 pubmed: 26347074 pmcid: 4628864
Gul A (2015) Genetics of Behçet’s disease: lessons learned from genomewide association studies. Curr Opin Rheumatol 26:56–63
doi: 10.1097/BOR.0000000000000003
Sousa I, Shahram F, Francisco D, Davatchi F, Abdollahi BS, Ghaderibarmi F, Nadji A, Mojarad Shafiee N, Xavier JM, Oliveira SA (2015) Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 with Behçet’s disease in Iranians. Arthritis Rheumatol 67(10):2742–2748
doi: 10.1002/art.39240 pubmed: 26097239
Ohno S, Asanuma T, Sugiura S, Wakisaka A, Aizawa M, Itakura K (1978) HLA-Bw51 and Behçet’s disease. JAMA 240(6):529
doi: 10.1001/jama.1978.03290060031006 pubmed: 671660
Xavier JM, Davatchi F, Abade O, Shahram F, Francisco V, Abdollahi BS, Trindade H, Nadji A, Shafiee NM, Ghaderibarmi F, Ligeiro D, Oliveira SA (2015) Characterization of the major histocompatibility complex locus association with Behçet’s disease in Iran. Arthritis Res Ther 17:81
doi: 10.1186/s13075-015-0585-6 pubmed: 25889189 pmcid: 4415285
Takeuchi M, Ombrello MJ, Kirino Y, Erer B, Tugal-Tutkun I, Seyahi E et al (2016) A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet’s disease in HLA-B*51 carriers. Ann Rheum Dis 75(12):2208–2211
doi: 10.1136/annrheumdis-2015-209059 pubmed: 27217550 pmcid: 5106293
Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E et al (2013) Genome-wide association analysis identifies new susceptibility loci for Behçet’s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 45(2):202–207
doi: 10.1038/ng.2520 pubmed: 23291587 pmcid: 3810947
Kang EH, Kim S, Park MY, Choi JY, Choi IA, Kim MJ, Ha YJ, Lee EY, Lee YJ, Lee EB, Kang C, Song YW (2017) Behçet’s disease risk association fine-mapped on the IL23R-IL12RB2 intergenic region in Koreans. Arthritis Res Ther 19(1):227
doi: 10.1186/s13075-017-1435-5 pubmed: 29017598 pmcid: 5633897
Reeves E, Edwards CJ, Elliott T, James E (2013) Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 191:35–43
doi: 10.4049/jimmunol.1300598 pubmed: 23733883 pmcid: 3785127
Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, von Delft F, Kavanagha KL, Brown MA et al (2011) Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci USA 108:7745–7750
doi: 10.1073/pnas.1101262108 pubmed: 21508329
Ombrello MJ, Kastner DL, Remmers EF (2015) Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: genetics. Curr Opin Rheumatol 27:349–356
doi: 10.1097/BOR.0000000000000189 pubmed: 26002026 pmcid: 4565054
Conde-Jaldon M, Montes-Cano MA, Garcia-Lozano JR, Ortiz-Fernandez L, Ortego-Centeno N, Gonzalez-Leon R et al (2014) Epistatic interaction of ERAP1 and HLA-B in Behçet disease: a replication study in the Spanish population. PLoS ONE 9:1–6
doi: 10.1371/journal.pone.0102100
Weichsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N et al (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335(8697):1078–1080
Evans DM, Purcell S (2012) Power calculation in genetic studies. Cold Spring Harb Protoc 2012(6):664–674
doi: 10.1101/pdb.top069559 pubmed: 22661434
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249
doi: 10.1038/nmeth0410-248 pubmed: 20354512 pmcid: 2855889
Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT (2011) Basic statistical analysis in genetic case-control studies. Nat Protoc 6(2):121–133
doi: 10.1038/nprot.2010.182 pubmed: 21293453 pmcid: 3154648
Szumilas M (2010) Explaining Odds Ratios. J Can Acad Child Adoles Psychiarty 19(3):227–229
Al-Okaily F, Arfin M, Al-Rashidi S, Al-Balawi M, Al-Asm A (2015) Inflammation-related cytokine gene polymorphisms in Behçet’s disease. Journal of Inflammation Research 8:173–180
pubmed: 26451120 pmcid: 4592046
Core Team R (2016) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Wang X, Ma J, Ma J, Wen Y, Meng L, Yang H, Zhang R, Hao D (2017) Bioinformatics analysis of genetic variants of endoplasmic reticulum aminopeptidase 1 in ankylosing spondylitis. Mol Med Rep 16:6532–6543
doi: 10.3892/mmr.2017.7417 pubmed: 28901420 pmcid: 5865822

Auteurs

Maria Carmela Padula (MC)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy.
Department of Science, University of Basilicata, Potenza, Italy.

Pietro Leccese (P)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy. pietroleccese1979@gmail.com.

Emanuela Pellizzieri (E)

Department of Science, University of Basilicata, Potenza, Italy.

Angela Anna Padula (AA)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy.

Michele Gilio (M)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy.

Teresa Carbone (T)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy.

Nancy Lascaro (N)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy.

Giuseppina Tramontano (G)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy.

Giuseppe Martelli (G)

Department of Science, University of Basilicata, Potenza, Italy.

Salvatore D'Angelo (S)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy.
Fondazione Basilicata Ricerca Biomedica (BRB), Potenza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH